Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerobic training and resveratrol in metabolic syndrome
IRCT20190204042615N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of resveratrol in cardiometabolic risk (CMR), sponsored by Islamic Azad University. Started Jun 2018; status: completed.
02
Drugs
resveratrol
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT20190204042615N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190204042615N1.